{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:22:20Z","timestamp":1783689740919,"version":"3.55.0"},"reference-count":39,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009045","name":"Jagiellonian University Medical College","doi-asserted-by":"publisher","award":["K\/ZDS\/007938"],"award-info":[{"award-number":["K\/ZDS\/007938"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Paracetamol is a popular and easily available drug which is used world-wide as analgesic, antipyretic agent. Hypersensitivity reactions to this drug involve a wide range of symptoms of various importance for patient management. The EudraVigilance (EV) database serves as a system for monitoring adverse events (AE) due to drug intake. We retrospectively recorded AE reports for \u201cparacetamol\u201d reported from 1 January 2007 to 1 October 2018 which fulfilled the category of \u201cserious\u201d in EV. For further analysis the retrieved AE reports were selected according to the keywords corresponding to hypersensitivity symptoms. We included in the study 4589 AE reports with 9489 particular AEs. 24.2% of all the AE reports concerned children. The most often reported symptoms were \u201cangioedema,\u201d \u201crash\u201d and \u201curticaria\u201d (each of them with a frequency of &gt;10% in the AE reports). An important group of AEs were oedema reported as being located in the head, neck or respiratory tract. We recorded 58 AE reports with fatal outcomes, including 9 Stevens-Johnson syndrome\/toxic epidermal necrolysis cases (SJS\/TEN), 10 anaphylactic reactions, 21 cases of hepatic failure and a further 18 cases which occurred for other reasons. SJS\/TEN, acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms were reported 129, 42 and 25 times, respectively. Prodromes and symptoms of potentially life-threating SJS\/TEN appeared in 286 of the AE reports. 380 AE reports pointed to a diagnosis of anaphylaxis. To improve patient safety, healthcare professionals, including pharmacists, can identify warning signs of severe hypersensitivity reactions to paracetamol.<\/jats:p>","DOI":"10.3390\/pharmacy7010012","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T02:22:23Z","timestamp":1547778143000},"page":"12","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hypersensitivity Reactions in Serious Adverse Events Reported for Paracetamol in the EudraVigilance Database, 2007\u20132018"],"prefix":"10.3390","volume":"7","author":[{"given":"Iwona","family":"Popio\u0142ek","sequence":"first","affiliation":[{"name":"Toxicology Ward, University Hospital in Krakow, Sniadeckich 10, 31-531 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2162-765X","authenticated-orcid":false,"given":"Katarzyna","family":"Piotrowicz-W\u00f3jcik","sequence":"additional","affiliation":[{"name":"Department of Clinical and Environmental Allergology, Jagiellonian University Medical College, 31-531 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6146-0188","authenticated-orcid":false,"given":"Grzegorz","family":"Porebski","sequence":"additional","affiliation":[{"name":"Department of Clinical and Environmental Allergology, Jagiellonian University Medical College, 31-531 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"key":"ref_1","first-page":"11","article-title":"Paracetamol: Mechanism of action, applications and safety concern","volume":"71","author":"Nowak","year":"2014","journal-title":"Acta Pol. Pharm."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"h3705","DOI":"10.1136\/bmj.h3705","article-title":"Where are we now with paracetamol?","volume":"351","author":"Dear","year":"2015","journal-title":"BMJ"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/bjaceaccp\/mkt049","article-title":"Paracetamol: Mechanisms and updates","volume":"14","author":"Sharma","year":"2014","journal-title":"Contin. Educ. Anaesth. Crit. Care Pain"},{"key":"ref_4","unstructured":"(2018, December 27). Drugs.com Paracetamol Side Effects. Available online: https:\/\/www.drugs.com\/sfx\/paracetamol-side-effects.html."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2125.2010.03819.x","article-title":"Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity: Outcome following unintentional paracetamol overdose","volume":"71","author":"Craig","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_6","unstructured":"(2018, December 27). European Medicines Agency EudraVigilance. Available online: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/pharmacovigilance\/eudravigilance."},{"key":"ref_7","unstructured":"(2018, December 27). The European Parliament and The Council Directive 2001\/83\/EC of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use. Available online: https:\/\/ec.europa.eu\/health\/sites\/health\/files\/files\/eudralex\/vol\u20131\/dir_2001_83_consol_2012\/dir_2001_83_cons_2012_en.pdf."},{"key":"ref_8","unstructured":"(2018, December 27). European Medicines Agency 2017 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission. Available online: https:\/\/www.ema.europa.eu\/documents\/report\/2017-annual-report-eudravigilance-european-parliament-council-commission-reporting-period-1-january_en.pdf."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Celik, G., Pichler, W., and Adkinson, N. (2009). Drug Allergy. Middleton\u2019s Allergy: Principles & Practice, Mosby\/Elsevier.","DOI":"10.1016\/B978-0-323-05659-5.00068-1"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2165\/00002018-200528100-00003","article-title":"Clarification of terminology in drug safety","volume":"28","author":"Aronson","year":"2005","journal-title":"Drug Saf."},{"key":"ref_11","first-page":"131","article-title":"Acetaminophen-Induced Hepatotoxicity: A Comprehensive Update","volume":"4","author":"Yoon","year":"2016","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000335213","article-title":"Paracetamol hypersensitivity: Clinical features, mechanism and role of specific IgE","volume":"159","author":"Rutkowski","year":"2012","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/0976-237X.166838","article-title":"Paracetamol induced Steven-Johnson syndrome: A rare case report","volume":"6","author":"Rajput","year":"2015","journal-title":"Contemp. Clin. Dent."},{"key":"ref_14","unstructured":"(2018, November 29). FDA Drug Safety Communication FDA Warns of Rare but Serious Skin Reactions with the Pain Reliever\/Fever Reducer Acetaminophen, Available online: https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm363041.htm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/cc1475","article-title":"Acetaminophen toxicity: Suicidal vs. accidental","volume":"6","author":"Gyamlani","year":"2002","journal-title":"Crit Care"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1586\/17512433.2014.904744","article-title":"A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States","volume":"7","author":"Blieden","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Pichler, W.J. (2007). Clinic and Pathogenesis of Severe Bullous Skin Reactions: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis. Drug Hypersensitivity, Karger.","DOI":"10.1159\/isbn.978-3-318-01454-9"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/ph3010010","article-title":"Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs: An Update","volume":"3","year":"2010","journal-title":"Pharmaceuticals"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40413-015-0080-1","article-title":"2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines","volume":"8","author":"Simons","year":"2015","journal-title":"World Allergy Organ. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.alit.2016.04.019","article-title":"Acetaminophen anaphylaxis diagnosed by skin prick test","volume":"65","author":"Numata","year":"2016","journal-title":"Allergol. Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0091-6749(95)70290-3","article-title":"Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects","volume":"96","author":"Settipane","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_22","first-page":"395","article-title":"Hypersensitivity to antipyretics: Pathogenesis, diagnosis and management","volume":"23","author":"Lee","year":"2017","journal-title":"Hong Kong Med. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00128071-200102060-00001","article-title":"Do Women Have More Adverse Drug Reactions?","volume":"2","author":"Rademaker","year":"2001","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199550010-00001","article-title":"Gender as a Risk Factor for Adverse Events to Medications","volume":"50","author":"Kando","year":"1995","journal-title":"Drugs"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00228-018-2480-y","article-title":"Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs","volume":"74","author":"Rydberg","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40801-018-0134-0","article-title":"Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database","volume":"5","author":"Toki","year":"2018","journal-title":"Drugs Real World Outcomes"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s40264-016-0455-4","article-title":"A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals","volume":"39","author":"Stergiopoulos","year":"2016","journal-title":"Drug Saf."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00045391-200007020-00010","article-title":"Paracetamol efficacy and safety in children: The first 40 years","volume":"7","author":"Cranswick","year":"2000","journal-title":"Am. J. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2710.2006.00754.x","article-title":"Efficacy and safety of over-the-counter analgesics in the treatment of common cold and flu","volume":"31","author":"Eccles","year":"2006","journal-title":"J. Clin. Pharmacy Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaip.2013.12.004","article-title":"Selective hypersensitivity reactions to acetaminophen: A 13-case series","volume":"2","year":"2014","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/all.12437","article-title":"Anaphylaxis: Guidelines from the European Academy of Allergy and Clinical Immunology","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjd.14530","article-title":"U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"174","author":"Creamer","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Feldmeyer, L., Heidemeyer, K., and Yawalkar, N. (2016). Acute Generalized Exanthematous Pustulosis: Pathogenesis, Genetic Background, Clinical Variants and Therapy. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17081214"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000335625","article-title":"Acute Generalized Exanthematous Pustulosis","volume":"Volume 97","author":"French","year":"2012","journal-title":"Chemical Immunology and Allergy"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.dsi.2013.09.006","article-title":"Drug reaction with eosinophilia and systemic symptoms: A drug-induced hypersensitivity syndrome with variable clinical features","volume":"31","author":"Chen","year":"2013","journal-title":"Dermatol. Sin."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Porebski, G. (2017). In Vitro Assays in Severe Cutaneous Adverse Drug Reactions: Are They Still Research Tools or Diagnostic Tests Already?. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081737"},{"key":"ref_37","first-page":"823","article-title":"Cytotoxic-based assays in delayed drug hypersensitivity reactions induced by antiepileptic drugs","volume":"125","author":"Czarnobilska","year":"2015","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s40264-017-0530-5","article-title":"The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis","volume":"40","author":"Rolfes","year":"2017","journal-title":"Drug Saf."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bcp.13098","article-title":"The value of patient reporting to the pharmacovigilance system: A systematic review: The value of patient reporting to the pharmacovigilance system","volume":"83","author":"Cavaco","year":"2017","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/7\/1\/12\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:26:41Z","timestamp":1760185601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/7\/1\/12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["pharmacy7010012"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy7010012","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,17]]}}}